Log in to save to my catalogue

Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteopo...

Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteopo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cb6322900fea42eba21cc6547c95e96d

Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis

About this item

Full title

Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis

Publisher

England: BioMed Central Ltd

Journal title

BMC musculoskeletal disorders, 2022-11, Vol.23 (1), p.1027-9, Article 1027

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Both denosumab and bisphosphonates have been demonstrated effective for glucocorticoid-induced osteoporosis. However, evidence-based medicine is still lacking to prove the clinical results between denosumab and bisphosphonates. This meta-analysis aims to compare the efficacy and safety between denosumab and oral bisphosphonates for the treatment of...

Alternative Titles

Full title

Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cb6322900fea42eba21cc6547c95e96d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cb6322900fea42eba21cc6547c95e96d

Other Identifiers

ISSN

1471-2474

E-ISSN

1471-2474

DOI

10.1186/s12891-022-05997-0

How to access this item